Related Experiment Video
Updated: Dec 18, 2025
02:21
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
1.2K
Recent advances in managing Peyronie's disease
1Department of Urology, Leeds Teaching Hospitals, Leeds, UK.
F1000Research
|June 11, 2020
Summary
Peyronie
Area of Science:
- Urology
- Sexual Medicine
Background:
- Peyronie's disease presents significant clinical challenges.
- Current treatments offer limited patient satisfaction and few molecular targets.
- Effective medical therapy options are scarce.
Purpose of the Study:
- To review the latest medical literature on Peyronie's disease management.
- To discuss contemporary evidence in treating men with this condition.
Main Methods:
- Comprehensive review of current medical literature.
- Analysis of evidence regarding contemporary management strategies.
Main Results:
- Treatment remains challenging with suboptimal patient outcomes.
- Limited novel therapeutic targets hinder medical advancements.
- Multifaceted approaches including counseling are often employed.
Conclusions:
- Managing Peyronie's disease requires careful counseling and combined treatments.
- Further research into molecular targets is needed for effective therapies.
Keywords:
PeyroniePeyronie’s diseasecollagenaseerectile dysfunctionfibrosisnon-surgical treatmenttraction therapytreatmenturologyMore Related Videos
03:55Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis
Published on: October 18, 2024
587
03:37Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats
Published on: October 11, 2024
619
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
171
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
171
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
416
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
416
01:26Peripheral Artery Disease IV: Nursing Management
231
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
231
01:26Atherosclerosis III: Management
259
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
259
01:26Peptic Ulcer Disease IV: Management
326
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
326
01:26Mitral Stenosis III: Medical Management
163
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
163